Live Chat

Giao dịch Amgen AMGN

Amgen biểu đồ trực tiếp

Hiểu biết sâu sắc

Weekly Search
Weekly
Daily
Ngày Đóng Thay đổi % Thay đổi Mở Cao Thấp

Tin tức

Thông tin

Chênh lệch

2.05

Tỷ lệ Spread (%)

0.6407 %

Đòn bẩy

1:10

Lãi suất Qua đêm Mua

-0.0597 %

Lãi suất Qua đêm Bán

-0.0292 %

Forex

USD

Giờ giao dịch

Thị trường đã đóng cửa.

Thứ sáu

13:31 - 19:59

Thứ hai

13:31-19:59

Thứ ba

13:31-19:59

Thứ tư

13:31-19:59

Thứ năm

13:31-19:59

Báo cáo thu nhập

Mở

---

Đóng trước đó

---

52 Tuần Cao/Thấp

--- – ---

Giá trị vốn hóa thị trường

173240254464

Cổ phiếu nổi bật

537329024

Ngày báo cáo thu nhập (tiếp theo)

1999-11-22

Tỷ suất cổ tức

2024-09-06

Ngày giao dịch không hưởng quyền

2024-08-16

Tỷ lệ cổ tức thường niên kỳ hạn

9

Tỷ suất cổ tức thường niên kỳ hạn

0.0279

EPS

5.8

Cổ phiếu nổi bật

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Tìm hiểu thêm về công cụ này

Các công cụ liên quan

Markets.com news

Keep up with the news as it happens and know what’s impacting the markets at any time.

Wall Street's leading indices notch fresh records ahead of US inflation data release later today

Thứ năm, 10 Tháng Mười 2024

Wall St. soars to new highs ahead of US inflation report

Thứ tư, 9 Tháng Mười 2024

Hang Seng index surges, breaking 21,000 mark

Thứ tư, 9 Tháng Mười 2024

Dow Jones index today: Dow Hit Record Closing Highs

Thứ tư, 9 Tháng Mười 2024

Nvidia stock surges 4% in Tuesday, notching its fifth straight day of gains

Live Chat